Le Lézard
Classified in: Health
Subjects: CHI, RCL, PSF

Advisory - Several children's strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles


OTTAWA, Nov. 14, 2018 /CNW/ -

Biomedic Acetaminophen (160 mg/5 mL) children's syrup, strawberry flavour (lot B0504-A) (CNW Group/Health Canada)

Issue
Laboratoire Riva Inc. and Laboratoires Trianon Inc. are voluntarily recalling several over-the-counter children's strawberry-flavoured acetaminophen syrups labeled as Biomedic, Option+, or Laboratoires Trianon Inc. The products, which are used for pain and fever relief, are being recalled because the child-resistant safety cap may be defective.

A defective cap could allow a child to accidentally ingest the product, which would pose a significant health concern. Accidental ingestion can result in acetaminophen overdose and serious health consequences, including liver damage in extreme cases. Early signs of overdose include nausea, vomiting, lethargy and sweating. Liver damage may result in liver failure or death. Abdominal pain may be the first sign of liver damage and may not be apparent for 24 to 48 hours.

This issue is related to product packaging and not the safety or effectiveness of the drug in the bottles. The products were distributed at major pharmacies across Canada.

Who is affected

Affected products

 

Description

Company

DIN

Lot

Expiry

Units Distributed

Biomedic Acetaminophen

(160 mg/5 mL) children's syrup, strawberry flavour 

Laboratoire Riva Inc.

02226871

B0504-A

21-MA

3,360

Option+ Acetaminophen oral solution USP

(160 mg/5 mL) children's syrup, strawberry flavour 

Laboratoire Riva Inc.

02226871

B0504-C

2021-MA

2,364

Laboratoires Trianon Inc. Acetaminophen Oral solution USP

(160 mg/5 mL) children's syrup, strawberry flavour

Laboratoires Trianon Inc.

01958836

B0504-B

21-MA

998

B0504-E

2021-MA

2,264

 

What consumers should do

What Health Canada is doing
Health Canada is monitoring the recalls. Should additional safety concerns be identified related to this issue, Health Canada will take appropriate action and inform Canadians as necessary.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

 

Option+ Acetaminophen (160 mg/5 mL) children's syrup, strawberry flavour (lot B0504-C) (CNW Group/Health Canada)

Laboratoires Trianon Inc. Acetaminophen (160 mg/5 mL) children's syrup, strawberry flavour (lot B0504-E) (CNW Group/Health Canada)

Laboratoires Trianon Inc. Acetaminophen (160 mg/5 mL) children's syrup, strawberry flavour (lot B0504-B) (CNW Group/Health Canada)

SOURCE Health Canada


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: